Imaged parent items

News

Submitted by admin on Fri, 06/27/2008 - 00:00

Are You Using Complementary/Alternative Therapies? It’s Time to Talk, Says the NIH

Submitted by admin on Thu, 06/19/2008 - 00:00

Laquinimod Results Published: Oral Drug Reduces Disease Activity in Phase 2 Study

Submitted by admin on Thu, 06/19/2008 - 00:00

Molecule Strikes Balance in Immune System and May Be Key to Autoimmune Attack in MS

Submitted by admin on Thu, 06/12/2008 - 00:00

Clinical Trials in Multiple Sclerosis 2008

Submitted by admin on Thu, 06/12/2008 - 00:00

MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People at High Risk for MS Worldwide

Submitted by admin on Wed, 06/11/2008 - 00:00

Small Study Suggests High Dose Regimen of Cancer Drug Cyclophosphamide Reduces MS Disease Activity

Submitted by admin on Fri, 06/06/2008 - 00:00

Serious Infections – One Fatal – Experienced by Two People Participating in Clinical Trials of FTY720 for MS

Submitted by admin on Thu, 06/05/2008 - 00:00

Society-Funded Study: Cell Transplants Lead to Neurological Recovery in Some Mice Born without Myelin

Submitted by admin on Thu, 06/05/2008 - 00:00

Long-Term Study Yields Clues for Predicting Future Course of MS

Submitted by admin on Wed, 06/04/2008 - 00:00

U.S. Veteran Living with MS Testifies Before Congress

Pages

Stony Brook University Hospital
101 Nicolls Road Stony Brook, NY 11794
(631) 444-4000